Related Experiment Video
Updated: Apr 21, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy
Karthik Shekha1, Joydeep Ghosh, Deepak Thekkoott
1Department of Cardiology and Clinical Electrophysiology, Maimonides Medical Center (Mount Sinai Health System), Brooklyn, New York 11219, USA.
Insights
Non-ischemic dilated cardiomyopathy (NIDCM) shares symptoms with heart failure and can lead to sudden cardiac death (SCD). Identifying high-risk NIDCM patients for targeted interventions remains a clinical challenge.
Area of Science:
- Cardiology
- Internal Medicine
- Pathology
Background:
- Non-ischemic dilated cardiomyopathy (NIDCM) is a myocardial disorder with diverse causes.
- NIDCM presents with heart failure symptoms and, rarely, sudden cardiac death (SCD).
- Its manifestations mimic ischemic dilated cardiomyopathy (IDCM).
Purpose of the Study:
- To review existing data on risk stratification in NIDCM.
- To analyze the clinical implications of NIDCM risk stratification.
- To identify patients at high risk for SCD despite medical management.
Main Methods:
- Systematic review of current literature on NIDCM.
- Analysis of risk stratification strategies for NIDCM.
- Evaluation of clinical data regarding patient outcomes.
Main Results:
- A subset of NIDCM patients faces a significant risk of SCD from ventricular arrhythmias.
- Accurate identification of high-risk NIDCM individuals is challenging.
- Current risk stratification methods and their practical applications are under examination.
Conclusions:
- Effective risk stratification is crucial for managing NIDCM patients prone to SCD.
- Targeted interventions can potentially improve outcomes and reduce healthcare costs associated with ICDs.
- Further research is needed to refine risk assessment and guide clinical practice in NIDCM.
Abstract:
Non ischemic dilated cardiomyopathy (NIDCM) is a disorder of myocardium. It has varying etiologies. Albeit the varying etiologies of this heart muscle disorder, it presents with symptoms of heart failure, and rarely as sudden cardiac death (SCD). Manifestations of this disorder are in many ways similar to its counterpart, ischemic dilated cardiomyopathy (IDCM). A proportion of patients with NIDCM carries a grave prognosis and is prone to sudden cardiac death from sustained ventricular arrhythmias. Identification of this subgroup of patients who carry the risk of sudden cardiac death despite adequate medical management is a challenge. Yet another method is a blanket treatment of patients with this disorder with anti arrhythmic medications or anti tachyarrhythmia devices like implantable cardioverter defibrillators (ICD). However this modality of treatment could be a costly exercise even for affluent economies. In this review we try to analyze the existing data of risk stratification of NIDCM and its clinical implications in practice.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

